From The Motley Fool · Motley Fool Transcribing · · 2m
HCA Q3 2026 Earnings Report Highlights
HCA Healthcare reports 3% same facility admissions growth with Medicaid supplement benefits rising to $600-800 million for 2026 amid payer mix shifts.
In brief
HCA Healthcare reports 3% same facility admissions growth with Medicaid supplement benefits rising to $600-800 million for 2026 amid payer mix shifts. HCA Healthcare reported 3% same facility admissions growth in Q3 2026 with Medicaid supplemental payments expected to reach $600-800 million for 2026 despite payer mix…
Q3 2026 Results
HCA Healthcare reported 3% same facility admissions growth in Q3 2026.
Revenue and Net Income
Revenue increased 3.6% to $19.849 billion, net income rose to $1.579 billion.
Medicaid Supplemental Payments
Medicaid supplemental payments reached $50 million in Q3 2026, with full year 2026 estimate raised to $600-800 million.
Payer Mix Impact
Payer mix shifts caused approximately $400 million unfavorable impact on adjusted EBITDA.
Uninsured Volume
Uninsured volume accounted for 10.5% of total equivalent admissions in Q3 2026.
Surgical Volumes
Inpatient surgeries declined 1.4%, outpatient surgeries dropped 3.7% in Q3 2026.
Exchange Equivalent Admissions
Exchange equivalent admissions declined 19% year over year, improving 8% sequentially from Q2 2026.
Capital Expenditures
Capital expenditures totaled $1.357 billion focused on hospital expansion and inpatient capacity.
Share Repurchases
Share repurchases totaled $2.970 billion for 7.230 million shares in Q3 2026.
2027 Outlook
2027 volume growth forecasted at 2-3%, adjusted EBITDA expected to be consistent with 2026 levels.
Medicaid Headwind
Medicaid supplemental payment net benefits expected to decline $550-650 million in 2027.
Operational Costs
Same facility operating costs remained flat per equivalent admission excluding Medicaid programs.
Professional Fees
Professional fees increased 12% year over year, driven by radiology and anesthesiology costs.
340B Program
HCA expects proposed Medicare OPPS rule to be a positive factor for 340B drug pricing.
HICS Impact
HICS volumes declined 19% year over year, improving 8% sequentially from Q2 2026.
2027 Strategic Focus
HCA prioritizes digital transformation, network development, and caregiver environment improvements.
The one thing
HCA Healthcare reported 3% same facility admissions growth in Q3 2026 with Medicaid supplemental payments expected to reach $600-800 million for 2026 despite payer mix headwinds.
